Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep1163 | Late Breaking | ECE2022

Sex difference in the association of cortisol excess severity with osteoporosis and osteopenia prevalence in cortisol-producing adrenal adenoma

Izawa Shoichiro , Matsumoto Kazuhisa , Matsuzawa Kazuhiko , Katabami Takuyuki , Yoshimoto Takanobu , Otsuki Michio , Sone Masakatsu , Takeda Yoshiyu , Okamura Shintaro , Ichijo Takamasa , Tsuiki Mika , Suzuki Tomoko , Naruse Mitsuhide , Tanabe Akiyo

Objective: Osteoporosis and osteopenia (OS/OP) are frequent in patients with cortisol-producing adrenal adenomas (CPA) associated with severity of cortisol excess (CE). However, the relationship between OS/OP and CE severity considering sex differences is unknown.Patients and Methods: This was a retrospective cross-sectional observational study conducted as a part of the Advancing Care and Pathogenesis of Intractable Adrenal Disease in Japan (ACPA-J) stu...

ea0090rc9.6 | Rapid Communications 9: Adrenal and Cardiovascular Endocrinology 2 | ECE2023

Immunohistochemical analysis of somatostatin receptor 2 and the tumor microenvironment in a large set of pheochromocytomas and paragangliomas

Uchihara Masaki , Tanabe Akiyo , Umamoto Kotaro , Maeshima Akiko Miyagi , Kojima Yuki , Sudo Kazuki , Shimoi Tatsunori , Yamazaki Yuto , Sasano Hironobu , Shimomura Akihiko , Shimizu Chikako , Yonemori Kan , Kajio Hiroshi

Introduction: Pheochromocytoma and paraganglioma (PPGL) are rare endocrine tumors with few effective treatment options for malignant cases. Novel therapeutic indications, such as 177Lu-DOTA-TATE and immune checkpoint inhibitors (ICIs) for patients with PPGL, have been investigated in several clinical trials. Emerging evidence shows that somatostatin receptor 2 (SSTR2) in other cancer types correlates with the tumor microenvironment (TME) activation and could be a predictive bi...